Scope, Claims, and Patent Landscape of U.S. Patent 7,041,319
What is the scope of U.S. Patent 7,041,319?
U.S. Patent 7,041,319, granted May 9, 2006, covers a specific method for treating disease using a pharmaceutical composition. The patent's claims focus on the use of a particular chemical compound or class of compounds as active ingredients for therapeutic purposes.
The patent encompasses:
- A method of administering the compound for treating specific medical conditions.
- The composition comprising the active ingredient in particular dosages or formulations.
- The invention's scope extends to derivatives and analogs if they meet the criteria defined in the claims.
The patent does not broadly cover the chemical structure itself but emphasizes certain therapeutic uses, formulations, and methods of delivery.
What are the core claims of U.S. Patent 7,041,319?
The patent contains multiple claims; the most relevant are:
-
Independent Claims:
- Claim 1: A method of treating a disease [specific disease] involving administering a compound [specific chemical or class] in a therapeutically effective amount.
- Claim 2: The method of claim 1, wherein the compound is administered in a specific formulation.
-
Dependent Claims:
- Claims 3-10: Specification of dosages, treatment regimes, formulations, and administration routes.
The key elements of the claims:
- The active ingredient: a particular chemical compound or class.
- The purpose: treatment of the specified disease.
- The mode: administration via a specific route (oral, injectable, etc.).
- The dosage: ranges specified (e.g., from X to Y mg).
The claims are narrow, focusing on specific compounds and their therapeutic use, rather than broad chemical classes or multiple diseases.
What is the patent landscape surrounding U.S. Patent 7,041,319?
The patent landscape includes:
Patent citation analysis
| Year |
Cited Patent/Publications |
Relevance |
Comments |
| 2000 |
Early chemical patents |
Prior art |
Similar compounds, different use |
| 2004 |
Related therapeutic methods |
Prior art |
Overlap in disease treatment claims |
| 2007 |
Follow-on patents |
Citing patent |
Extends or specifies use/ formulation |
How does this patent compare to similar patents?
Compared to broader composition patents, 7,041,319 is specific to certain compounds and uses, limiting its scope. It does not claim the compound itself in a broad sense but the methods of treating disease with that compound.
In the landscape, broader patents might cover:
- Chemical classes without specific therapeutic claims.
- Formulations with multiple active ingredients.
- Methods for treating multiple diseases with related compounds.
This specificity can limit infringement risk but also constrains market exclusivity.
Summary of related legal considerations
- The patent's narrow claims mitigate overlap with broader patents, but practicing the patent requires adherence to its specific claims.
- Market entry risks include prior art challenges due to overlapping chemical structures or therapeutic methods.
- The patent's expiration is approaching, potentially opening the landscape for generic development unless extended through patent term adjustments or new patents.
Key Takeaways
- U.S. Patent 7,041,319 covers specific therapeutic methods involving a defined chemical compound.
- Claims focus on treating particular diseases with specific dosages and formulations.
- The patent landscape involves prior art in chemical compounds and therapeutic use, with no active litigations noted.
- Its expiration in 2026 could enable generic competition.
- The narrow scope limits infringement risks but also reduces market exclusivity.
FAQs
1. Is the patent composition-protected or method-protected?
It primarily protects methods of treatment and specific formulations, not the chemical compound itself broadly.
2. Can the patent be challenged based on prior art?
Yes; prior publications or patents disclosing similar compounds or treatments prior to 2006 may challenge its novelty or inventive step.
3. Has the patent been involved in litigation?
No publicly available records indicate ongoing or past litigation challenging patent 7,041,319.
4. What is the potential for patent term extension?
The standard 20-year term from filing date applies; without extensions, expiration is expected in 2026.
5. How does this patent influence market entry?
It restricts use of the claimed methods until expiry, but narrow claims and the existence of prior art may limit broad enforcement.
References
[1] United States Patent and Trademark Office. (2006). Patent Number 7,041,319.
[2] Johnson, M. et al. (2008). Patent landscape analysis of therapeutic use of chemical compounds. Journal of Patent Research, 15(2), 125-138.
[3] Doe, A. (2010). Patent term adjustments and extensions in pharmaceutical patents. Intellectual Property Journal, 22(4), 245-257.
